Lannett Company, Inc.

Symbol: LCI

NYSE

0.6855

USD

Market price today

  • -0.0426

    P/E Ratio

  • -0.0005

    PEG Ratio

  • 7.38M

    MRK Cap

  • 0.00%

    DIV Yield

Lannett Company, Inc. (LCI) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.18%

Operating Profit Margin

-0.14%

Net Profit Margin

-0.70%

Return on Assets

-0.50%

Return on Equity

0.50%

Return on Capital Employed

0.08%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO:Mr. Timothy C. Crew
Full-time employees:564
City:Trevose
Address:1150 Northbrook Drive
IPO:2013-12-13
CIK:0000057725

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

General Outlook

When we look at how much money they make before expenses, they keep 0.178% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.138%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.701%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.495% return, is a testament to Lannett Company, Inc.'s adeptness in optimizing resource deployment. Lannett Company, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.496%. Furthermore, the proficiency of Lannett Company, Inc. in capital utilization is underscored by a remarkable 0.082% return on capital employed.

Stock Prices

Lannett Company, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.12, while its low point bottomed out at $0.0221. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Lannett Company, Inc.'s stock market.

Liquidity Ratios

Analyzing LCI liquidity ratios reveals its financial health of the firm. The current ratio of 35.70% gauges short-term asset coverage for liabilities. The quick ratio (15.65%) assesses immediate liquidity, while the cash ratio (6.35%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio35.70%
Quick Ratio15.65%
Cash Ratio6.35%

Profitability Ratios

LCI profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -70.07% underscores its earnings before tax deductions. The effective tax rate stands at -0.06%, revealing its tax efficiency. The net income per EBT, 100.06%, and the EBT per EBIT, 507.98%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -13.79%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-70.07%
Effective Tax Rate-0.06%
Net Income per EBT100.06%
EBT per EBIT507.98%
EBIT per Revenue-13.79%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.36, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding16
Days of Inventory Outstanding170
Operating Cycle275.66
Days of Payables Outstanding40
Cash Conversion Cycle236
Receivables Turnover3.47
Payables Turnover9.23
Inventory Turnover2.14
Fixed Asset Turnover11.00
Asset Turnover0.71

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -3.73, and free cash flow per share, -4.46, depict cash generation on a per-share basis. The cash per share value, 4.51, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.16, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-3.73
Free Cash Flow per Share-4.46
Cash per Share4.51
Operating Cash Flow Sales Ratio-0.16
Free Cash Flow to Operating Cash Flow Ratio1.20
Cash Flow Coverage Ratio-0.06
Short Term Coverage Ratio-0.06
Capital Expenditure Coverage Ratio-5.07
Dividend Paid and Capex Coverage Ratio-5.07

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 191.15%, highlights its total liabilities relative to assets. With a debt-equity ratio of -1.55, we discern the balance between debt and equity financing. The long-term debt to capitalization, -2.27%, and total debt to capitalization, 281.32%, ratios shed light on its capital structure. An interest coverage of -0.72 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio191.15%
Debt Equity Ratio-1.55
Long Term Debt to Capitalization-2.27%
Total Debt to Capitalization281.32%
Interest Coverage-0.72
Cash Flow to Debt Ratio-0.06
Company Equity Multiplier-0.81

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 33.76, provides a glimpse into top-line earnings distributed across each share. Net income per share, -22.96, reflects the portion of profit attributed to each share. The book value per share, -24.89, represents the net asset value distributed per share, while the tangible book value per share, -28.08, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share33.76
Net Income Per Share-22.96
Book Value Per Share-24.89
Tangible Book Value Per Share-28.08
Shareholders Equity Per Share-24.89
Interest Debt Per Share67.90
Capex Per Share-1.04

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 545,004,842.926, captures the company's total value, considering both debt and equity. Income quality, 0.03, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 6.64%, indicates the value of non-physical assets, and capex to operating cash flow, 147.21%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value545,004,842.926
Income Quality0.03
Research and Development to Revenue6.57%
Intangibles to Total Assets6.64%
Capex to Operating Cash Flow147.21%
Capex to Revenue-3.08%
Capex to Depreciation-30.61%
Stock-Based Compensation to Revenue2.47%
Graham Number113.39
Return on Tangible Assets-51.21%
Graham Net Net-52.57
Working Capital185,176,000
Tangible Asset Value-283,242,000
Net Current Asset Value-445,382,000
Invested Capital-2
Average Receivables113,459,000
Average Payables29,661,000
Average Inventory102,351,500
Days Sales Outstanding100
Days Payables Outstanding35
Days of Inventory On Hand113
ROIC-17.92%
ROE0.92%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -0.02, and the price to book ratio, -0.02, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.03, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.16, and price to operating cash flows, -0.18, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio-0.02
Price to Book Ratio-0.02
Price to Sales Ratio0.03
Price Cash Flow Ratio-0.18
Enterprise Value Multiple45.53
Price Fair Value-0.02
Price to Operating Cash Flow Ratio-0.18
Price to Free Cash Flows Ratio-0.16
Price to Tangible Book Ratio-0.02
Enterprise Value to Sales1.60
Enterprise Value Over EBITDA-7.78
EV to Operating Cash Flow-76.49
Earnings Yield-3957.39%
Free Cash Flow Yield-300.95%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Lannett Company, Inc. (LCI) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.043 in 2024.

What is the ticker symbol of Lannett Company, Inc. stock?

The ticker symbol of Lannett Company, Inc. stock is LCI.

What is company IPO date?

IPO date of Lannett Company, Inc. is 2013-12-13.

What is company current share price?

Current share price is 0.685 USD.

What is stock market cap today?

The market cap of stock today is 7380504.000.

What is PEG ratio in 2024?

The current -0.000 is -0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 564.